Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CWBR | CohBar, Inc.

Index- P/E- EPS (ttm)-4.36 Insider Own0.20% Shs Outstand2.91M Perf Week-3.34%
Market Cap8.38M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float2.47M Perf Month2.12%
Income-12.70M PEG- EPS next Q- Inst Own7.20% Short Float / Ratio1.27% / 1.19 Perf Quarter-0.90%
Sales- P/S- EPS this Y39.80% Inst Trans-8.74% Short Interest0.03M Perf Half Y84.08%
Book/sh3.27 P/B0.88 EPS next Y- ROA-81.10% Target Price18.00 Perf Year-31.78%
Cash/sh4.24 P/C0.68 EPS next 5Y- ROE-88.90% 52W Range1.43 - 6.90 Perf YTD70.51%
Dividend- P/FCF- EPS past 5Y11.80% ROI- 52W High-58.12% Beta1.87
Dividend %- Quick Ratio4.20 Sales past 5Y- Gross Margin- 52W Low102.10% ATR0.21
Employees9 Current Ratio4.20 Sales Q/Q- Oper. Margin- RSI (14)48.46 Volatility5.18% 7.25%
OptionableNo Debt/Eq0.00 EPS Q/Q-58.60% Profit Margin- Rel Volume0.20 Prev Close2.91
ShortableYes LT Debt/Eq0.00 EarningsAug 14 AMC Payout- Avg Volume26.30K Price2.89
Recom3.00 SMA20-0.01% SMA50-2.80% SMA20024.45% Volume5,251 Change-0.69%
Date Action Analyst Rating Change Price Target Change
Mar-15-21Initiated Aegis Capital Buy $6
Aug-14-23 04:01PM
Jun-05-23 08:05AM
May-30-23 08:05AM
May-23-23 02:52PM
04:03PM Loading…
Nov-08-22 04:03PM
Oct-26-22 09:00AM
Oct-21-22 12:00PM
Sep-22-22 09:00AM
Sep-06-22 09:00AM
Aug-15-22 04:02PM
Aug-01-22 09:00AM
Jul-12-22 09:00AM
Jun-11-22 09:33AM
Jun-07-22 09:00AM
04:02PM Loading…
May-19-22 04:02PM
May-16-22 04:01PM
May-12-22 09:00AM
May-02-22 09:00AM
Mar-29-22 04:01PM
Mar-15-22 09:00AM
Jan-13-22 01:38PM
Jan-03-22 09:00AM
Dec-31-21 11:22AM
Dec-17-21 09:00AM
Nov-29-21 09:00AM
Nov-19-21 09:47AM
Nov-15-21 04:02PM
Nov-03-21 08:33AM
Nov-02-21 01:14AM
09:00AM Loading…
Nov-01-21 09:00AM
Oct-28-21 02:45PM
Oct-27-21 04:01PM
Oct-13-21 09:00AM
Sep-15-21 09:00AM
Sep-08-21 09:00AM
Sep-02-21 04:05PM
Aug-20-21 09:46AM
Aug-16-21 09:00AM
Aug-12-21 12:50PM
Aug-10-21 04:04PM
Aug-04-21 04:05PM
Jul-14-21 09:00AM
Jun-10-21 09:00AM
May-17-21 04:02PM
May-03-21 09:00AM
Apr-27-21 08:30AM
Apr-22-21 09:56AM
Apr-21-21 09:00AM
Apr-14-21 09:00AM
Mar-30-21 04:02PM
Mar-29-21 09:00AM
Mar-16-21 04:05PM
Mar-12-21 09:00AM
Mar-02-21 09:00AM
Feb-25-21 09:00AM
Feb-09-21 09:00AM
Jan-20-21 09:00AM
Jan-11-21 09:00AM
Dec-09-20 09:00AM
Nov-19-20 09:00AM
Nov-16-20 04:01PM
Nov-09-20 03:30PM
Nov-02-20 09:00AM
Oct-29-20 09:00AM
Oct-27-20 09:00AM
Oct-26-20 09:00AM
Oct-15-20 04:05PM
Oct-08-20 09:00AM
Oct-05-20 09:00AM
Sep-29-20 04:05PM
Sep-10-20 04:05PM
Sep-04-20 11:24AM
Sep-03-20 08:45AM
Aug-28-20 04:05PM
Aug-26-20 08:30AM
Aug-25-20 04:55PM
Aug-24-20 09:00AM
Aug-13-20 04:03PM
Aug-05-20 09:00AM
Jul-30-20 09:00AM
Jul-07-20 09:00AM
Jul-06-20 09:00AM
Jun-30-20 09:00AM
Jun-17-20 09:00AM
Jun-02-20 09:00AM
May-27-20 09:00AM
May-14-20 04:02PM
May-13-20 09:00AM
May-05-20 09:00AM
May-01-20 11:00AM
Apr-30-20 09:00AM
Apr-19-20 09:21AM
CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases. CohBar, Inc. was incorporated in 2007 and is based in Menlo Park, California.